Literature DB >> 9138112

Mode of c-myc protein expression in Spitz nevi, common melanocytic nevi and malignant melanomas.

R Bergman1, M Lurie, H Kerner, S Kilim, R Friedman-Birnbaum.   

Abstract

The expression of c-myc protein was studied in formalin-fixed, paraffin-embedded sections of 16 compound Spitz nevi (SNs), 20 ordinary compound melanocytic nevi (MNs) and 30 malignant melanomas (MMs), using monoclonal antibody 9E10 and an immunoperoxidase technique. Nine (56%) SNs, 16 (80%) MNs and 23 (77%) MMs showed positive reactions in some of the tumor cells (P = non-significant). The staining reactions were mostly cytoplasmic, and moderate to strong in intensity. The frequencies of positively stained cells were higher in the MN and SN groups. Most of the lesions with a significant dermal component did not show stratification of staining with progressive descent into the dermis. Therefore, the mode of expression of c-myc in routinely processed specimens does not differentiate between SNs, MNs and MMs. One possible reason is that the increased expression of the c-myc protein is not sufficient alone to promote proliferation and malignant transformation in these types of tumors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9138112     DOI: 10.1111/j.1600-0560.1997.tb01584.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  5 in total

1.  Wnt signaling potentiates nevogenesis.

Authors:  Jeff S Pawlikowski; Tony McBryan; John van Tuyn; Mark E Drotar; Rachael N Hewitt; Andrea B Maier; Ayala King; Karen Blyth; Hong Wu; Peter D Adams
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

2.  Expression of activated Akt in benign nevi, Spitz nevi and melanomas.

Authors:  Sara M Kantrow; Alan S Boyd; Darrel L Ellis; Lillian B Nanney; Ann Richmond; Yu Shyr; Jason B Robbins
Journal:  J Cutan Pathol       Date:  2007-08       Impact factor: 1.587

3.  Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases.

Authors:  G M Kraehn; J Utikal; M Udart; K M Greulich; G Bezold; P Kaskel; U Leiter; R U Peter
Journal:  Br J Cancer       Date:  2001-01-05       Impact factor: 7.640

4.  Acute Inhibition of MEK Suppresses Congenital Melanocytic Nevus Syndrome in a Murine Model Driven by Activated NRAS and Wnt Signaling.

Authors:  Jeffrey S Pawlikowski; Claire Brock; Sheau-Chiann Chen; Lara Al-Olabi; Colin Nixon; Fiona McGregor; Simon Paine; Estelle Chanudet; Wendy Lambie; William M Holmes; James M Mullin; Ann Richmond; Hong Wu; Karen Blyth; Ayala King; Veronica A Kinsler; Peter D Adams
Journal:  J Invest Dermatol       Date:  2015-03-27       Impact factor: 8.551

5.  Structure, expression and chromosome mapping of MLZE, a novel gene which is preferentially expressed in metastatic melanoma cells.

Authors:  K Watabe; A Ito; H Asada; Y Endo; T Kobayashi; K Nakamoto; S Itami; S Takao; Y Shinomura; T Aikou; K Yoshikawa; Y Matsuzawa; Y Kitamura; H Nojima
Journal:  Jpn J Cancer Res       Date:  2001-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.